Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software

Diabetes Technology and Therapeutics

Volumn 10, Issue 5, 2008, Pages 369-375

  Garg, Satish K ^a,b   Bookout, Tevin R ^a   McFann, Kim K ^a,b   Kelly, William C ^a   Beatson, Christie ^a   Ellis, Samuel L ^a,c   Gutin, Raymond S ^a,b   Gottlieb, Peter A ^a,b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; DEVICE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERSONAL DIGITAL ASSISTANT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; SOFTWARE;

EID: 50049100173     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0303     Document Type: Article

References (22)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-1685.
3. Diabetes Control and Complications Trial Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
4. Turner RC, Cull CA, Frighi V, Holman RR; the UK Prospective Diabetes Study (UKPDS Group): Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. JAMA 1998;281:2005-2012.
5. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
6. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R; the United Kingdom Prospective Diabetes Study Group: Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS 41). BMJ 2000;320:1373-1378.
7. Diabetes Control and Complications Trial Research Group: Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 1995;18:1468-1478.
8. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2005.
9. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003, rev ed. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2004.
10. Diabetes Epidemiology Research International Group: Secular trends in incidence of childhood IDDM in 10 countries. Diabetes Epidemiology Research International Group. Diabetes 1990;39:858-864.
11. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-1403.
12. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith J, Bloch C, Rewers M, Dabelea D: Increasing incidence of type 1 diabetes mellitus in 0-17 year old Colorado youth. Diabetes Care 2007;30:503-509.
13. Rizza R, Vigersky R, Rodbard H, Ladenson P, Young W, Surks M, Kahn R, Hogan P: A model to determine workforce needs for endocrinologists in the United States until 2020. Diabetes Care 2003;26:1545-1552.
14. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous implanted glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.
15. Garg SK, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycaemic control with a transcutaneous, real-time continuous glucose sensor: randomized controlled trial. Diabetes Care 2006;29:44-50.
16. Garg S, Jovanovic L: Clinical trial of a seven-day continuous glucose sensor demonstrates the importance of fasting hyperglycemia and the dawn phenomenon. Diabetes Care 2007;29:2644-2649.
17. Bailey TS, Zisser H, Garg SK: Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week Study. Diabetes Technol Ther 2007;9:203-210.
18. Garg SK, Kelly WC, Voelmle MK, Ritchie PJ, Gottlieb PA, McFann KK, Ellis SL: Improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007;30:3023-3025.
19. Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK: Postprandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2002;19:317-321.
20. Cnaan A, Laird NM, Slasor P: Tutorial in biostatistics, using the general linear model to analyze unbalanced repeated measures and longitudinal data. Statistics Med 1997;16:2349-2380.
21. Brewer KW, Owen S, Garg SK, Chase HP: Slicing the pie: correlating hemoglobin A1c (HbA1c) values with average blood glucose (ABG) values in a pie chart form. Diabetes Care 1998;21:209-212.
22. Schiffrin A, Belmonte M: Diabetes multiple daily self glucose monitoring: its essential role in long term glucose control in insulin dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982;5:479-484.